Received: 22 November 2019
Accepted: 14 July 2020
First Online: 23 July 2020
Ethics approval and consent to participate
: Ethical clearance was obtained from Bahir Dar University ethical review board. Permission letter was obtained from Amhara national regional, state health bureau ethics committee and the respective health facility heads. Written informed consent was obtained from each study participant. Study participants the right to withdraw from this research at any point was respected. The confidentiality of the data was kept at all stages. Study participants with hepatitis B or hepatitis C viral infections were linked to the available services in the health facilities.
: Not applicable.
: The authors declare that they have no competing interests.